TY - JOUR
T1 - Multiple negative feedbacks on CD152 expression in allograft tolerance
AU - Tsai, Meng-Kun
AU - Ho, Hong-Nerng
AU - Chien, Hsiung-Fei
AU - Tzeng, Mei-Ching
AU - Chen, Chien-Hsing
AU - Lee, Po-Huang
N1 - 被引用次數:1
Export Date: 16 March 2016
CODEN: TRPLA
通訊地址: Lee, P.-H.; Department of Surgery, National Taiwan University Hospital, No. 7, Chung-Shan South Road, Taipei, 100, Taiwan; 電子郵件: [email protected]
化學物質/CAS: Antigens, CD; Antigens, CD80; Antigens, CD86; Antigens, Differentiation; Cd86 protein, mouse; cytotoxic T-lymphocyte antigen 4; DNA Primers; Membrane Glycoproteins
製造商: Pharmingen, United States
參考文獻: Tivol, E., Borriello, F., Schweitzer, A., Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan destruction, revealing a critical negative regulatory role of CTLA-4 (1995) Immunity, 3, pp. 541-547; Waterhouse, P., Penninger, J., Timms, E., Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4 (1995) Science, 270, pp. 985-988; Carreno, B.M., Bennett, F., Chau, T.A., CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expression (2000) J Immunol, 165, pp. 1352-1356; Lee, K.M., Chuang, E., Griffin, M., Molecular basis of T cell inactivation by CTLA-4 (1998) Science, 282, pp. 2263-2266; Calvo, C.R., Amsen, D., Kruisbeek, A.M., Cytotoxic T lymphocyte antigen 4 (CTLA-4) interferes with extracellular NH2-terminal kinase (JNK) activation, but does not affect phosphorylation of T cell receptor zeta and ZAP70 (1997) J Exp Med, 186, pp. 1645-1653; Alegre, M.L., Noel, P.J., Eisfelder, B.J., Regulation of surface and intracellular expression of CTLA4 on mouse T cells (1996) J Immunol, 157, pp. 4762-4770; Walunas, T.L., Bakker, C.Y., Bluestone, J.A., CTLA-4 ligation blocks CD28-dependent T cell activation (1996) J Exp Med, 183, pp. 2541-2550; Dahlen, E., Hedlund, G., Dawe, K., Low CD86 expression in the nonobese diabetic mouse results in the impairment of both T cell activation and CTLA-4 up-regulation (2000) J Immunol, 164, pp. 2444-2456; Salomon, B., Lenschow, D.J., Rhee, L., B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes (2000) Immunity, 12, pp. 431-440; Salomon, B., Bluestone, J.A., Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation (2001) Annu Rev Immunol, 19, pp. 225-252; Judge, T.A., Wu, Z., Zheng, X.G., The role of CD80, CD86, and CTLA-4 in alloimmune responses and the induction of long-term allograft survival (1999) J Immunol, 162, pp. 1947-1951; Chai, J.G., Vendetti, S., Amofah, E., CD152 ligation by CD80 on T cells is required for the induction of unresponsiveness by costimulation-deficient antigen presentation (2000) J Immunol, 165, pp. 3037-3042; Bour-Jordan, H., Bluestone, J.A., CD28 function: A balance of costimulatory and regulatory signals (2002) J Clin Immunol, 22, pp. 1-7; Collins, A.V., Brodie, D.W., Gilbert, R.J.C., The interaction properties of costimulatory molecules revisited (2002) Immunity, 17, pp. 201-210; Tsai, M.K., Ho, H.N., Chien, H.F., The role of B7 ligands (CD80 and CD86) in CD 152-mediated allograft tolerance: A crosscheck hypothesis (2004) Transplantation, 77, pp. 48-54; Chen, Z., A technique of cervical heterotopic heart transplantation in mice (1991) Transplantation, 52, p. 1099; Kaithamana, S., Fan, J., Osuga, Y., Induction of experimental autoimmune Graves' disease in BALB/c mice (1999) J Immunol, 163, pp. 5157-5164; Tsai, M.K., Lin, R.H., Hsu, B.R., Lipofection of pcDNA3-CTLA4-Ig into B cells promotes allogeneic hyporesponsiveness (2003) Transplant Proc, 35, pp. 548-549; Ling, V., Wu, P.W., Finnerty, H.F., Complete sequence determination of the mouse and human CTLA4 gene loci: Cross-species DNA sequence similarity beyond exon borders (1999) Genomics, 60, pp. 341-355; Sheu, B.C., Lin, R.H., Ho, H.N., Down-regulation of CD25 expression on the surface of activated tumor-infiltrating lymphocytes in human cervical carcinoma (1997) Hum Immunol, 56, pp. 39-48; Wang, S.M., Hwang, R.D., Greenberg, A.S., Temporal and spatial assembly of lipid droplet-associated proteins in 3T3-L1 preadipocytes (2003) Histochem Cell Biol, 120, pp. 285-292; Roncarolo, M.G., Gregori, S., Levings, M., Type 1 T regulatory cells and their relationship with CD4+CD25+ T regulatory cells (2003) Novartis Found Symp, 252, pp. 115-131; Egen, J.G., Allison, J.P., Cytotoxic T lymphocyte antigen-4 accumulation in the immunological synapse is regulated by TCR signal strength (2002) Immunity, 16, pp. 23-35; Baroja, M.L., Vijayakrishnan, L., Bettelli, E., Inhibition of CTLA-4 function by the regulatory subunit of serine/threonine phosphatase 2A (2002) J Immunol, 168, pp. 5070-5078; Chuang, E., Alegre, M.L., Duckett, C.S., Interaction of CTLA-4 with the clathrin-associated protein AP50 results in ligand-independent endocytosis that limits cell surface expression (1997) J Immunol, 159, pp. 144-151; Sansom, D.M., Manzotti, C.N., Zheng, Y., What's the difference between CD80 and CD86 (2003) Trends Immunol, 24, pp. 313-317; Zheng, Y., Manzotti, C.N., Liu, M., CD86 and CD80 differentially modulate the suppressive function of human regulatory T cells (2004) J Immunol, 172, pp. 2778-2784; Lohr, J., Knoechel, B., Jiang, S., The inhibitory function of B7 costimulatiors in T cell responses to foreign and self-antigens (2003) Nat Immunol, 4, pp. 664-669; Boise, L.H., Minn, A.J., Noel, P.J., CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL (1995) Immunity, 3, pp. 87-98; Viola, A., Lanzavecchia, A., T cell activation determined by T cell receptor number and tunable thresholds (1996) Science, 273, pp. 104-106; Iida, T., Ohno, H., Nakaseko, C., Regulation of cell surface expression of CTLA-4 by secretion of CTLA-4-containing lysosomes upon activation of CD4+ T cells (2000) J Immumol, 165, pp. 5062-5068; Russell, P.S., Chase, C.M., Colvin, R.B., Alloantibody- and T cell-mediated immunity in the pathogenesis of transplant arteriosclerosis (1997) Transplantation, 64, p. 1531; Sprent, J., Schaefer, M., Lo, D., Properties of purified T cell subsets: II. In vivo response to class I vs class II H-2 differences (1986) J Exp Med, 165, p. 1296; Tsai, M.K., Ho, H.N., Chien, H.F., Visualization of the CD4+CD25+CTLA-4+ T-cell subset in long-term surviving cardiac allografts (2002) Transplantation, 74 (SUPPL.), p. 592; Ariyan, C., Salvalaggio, P., Fecteau, S., Cutting edge: Transplantation tolerance through enhanced CTLA-4 expression (2003) J Immunol, 171, pp. 5673-5677; Hori, S., Nomura, T., Sakaguchi, S., Control of regulatory T cell development by the transcription factor Foxp3 (2003) Science, 299, pp. 1057-1061
PY - 2005
Y1 - 2005
N2 - Background. CD152 has been implicated in tolerance induction. This study investigated how CD80 and CD86 regulated CD152 expression in a low-responding cardiac transplant model with CD152-mediated long-term graft acceptance. Methods. A low-responding cardiac transplant model from BALB/c to B10.A was used. Donor-specific stimulation and multiple antibody blockade of the CD80/CD86:CD28/CD152 co-stimulatory pathway was applied to the splenic T cells from B10.A recipients with 100-day grafts (B10.A-100). Proliferation assays, quantitative (Q) real-time polymerase chain reaction (PCR), flow cytometric analyses, and fluorescence microscopy were conducted to examine the roles of CD80 and CD86 in CD152 expression. Results. B10.A-100 splenic T cells were hyporesponsive to donor-specific stimulation, and anti-CD80, anti-CD86, or anti-CD152 treatment significantly enhanced the proliferation response of the B10.A-100 splenic T cells. Proliferation assays and Q-PCR revealed that CD152 inhibited T-cell proliferation and, at the same time, decreased CD152 expression by secluding CD80 and CD86 from CD28 engagement. Flow cytometric analyses and fluorescence microscopy showed that CD28 engagement facilitated intracellular accumulation of CD152. Besides, CD152 engagement by CD80 decreased CD152 mRNA transcription, and CD152 engagement by CD86 inhibited surface expression of CD152. Conclusions. CD80 and CD86 controlled CD152-mediated allograft tolerance by multiple negative feedbacks on CD152 mRNA and surface expression.
AB - Background. CD152 has been implicated in tolerance induction. This study investigated how CD80 and CD86 regulated CD152 expression in a low-responding cardiac transplant model with CD152-mediated long-term graft acceptance. Methods. A low-responding cardiac transplant model from BALB/c to B10.A was used. Donor-specific stimulation and multiple antibody blockade of the CD80/CD86:CD28/CD152 co-stimulatory pathway was applied to the splenic T cells from B10.A recipients with 100-day grafts (B10.A-100). Proliferation assays, quantitative (Q) real-time polymerase chain reaction (PCR), flow cytometric analyses, and fluorescence microscopy were conducted to examine the roles of CD80 and CD86 in CD152 expression. Results. B10.A-100 splenic T cells were hyporesponsive to donor-specific stimulation, and anti-CD80, anti-CD86, or anti-CD152 treatment significantly enhanced the proliferation response of the B10.A-100 splenic T cells. Proliferation assays and Q-PCR revealed that CD152 inhibited T-cell proliferation and, at the same time, decreased CD152 expression by secluding CD80 and CD86 from CD28 engagement. Flow cytometric analyses and fluorescence microscopy showed that CD28 engagement facilitated intracellular accumulation of CD152. Besides, CD152 engagement by CD80 decreased CD152 mRNA transcription, and CD152 engagement by CD86 inhibited surface expression of CD152. Conclusions. CD80 and CD86 controlled CD152-mediated allograft tolerance by multiple negative feedbacks on CD152 mRNA and surface expression.
KW - CD152
KW - CD80
KW - CD86
KW - Transplant tolerance
KW - B7 antigen
KW - B7 monoclonal antibody
KW - CD86 antigen
KW - cytotoxic T lymphocyte antigen 4
KW - lymphocyte antigen
KW - messenger RNA
KW - monoclonal antibody
KW - monoclonal antibody cd152
KW - monoclonal antibody CD28
KW - monoclonal antibody CD80
KW - monoclonal antibody cd86
KW - unclassified drug
KW - animal cell
KW - animal experiment
KW - antigen expression
KW - article
KW - controlled study
KW - female
KW - flow cytometry
KW - fluorescence microscopy
KW - heart graft
KW - heart transplantation
KW - lymphocyte proliferation
KW - mouse
KW - mouse strain
KW - negative feedback
KW - nonhuman
KW - organ donor
KW - priority journal
KW - real time polymerase chain reaction
KW - recipient
KW - RNA transcription
KW - spleen cell
KW - T lymphocyte
KW - transplantation tolerance
KW - Animals
KW - Antigens, CD
KW - Antigens, CD80
KW - Antigens, CD86
KW - Antigens, Differentiation
KW - Cell Division
KW - DNA Primers
KW - Female
KW - Heart Transplantation
KW - Immune Tolerance
KW - Lymphocyte Activation
KW - Membrane Glycoproteins
KW - Mice
KW - Mice, Inbred BALB C
KW - Mice, Inbred C57BL
KW - Polymerase Chain Reaction
KW - Reverse Transcriptase Polymerase Chain Reaction
KW - Spleen
KW - T-Lymphocytes
KW - Transcription, Genetic
KW - Transplantation, Homologous
U2 - 10.1097/01.TP.0000146428.03625.EB
DO - 10.1097/01.TP.0000146428.03625.EB
M3 - Article
SN - 0041-1337
VL - 79
SP - 174
EP - 181
JO - Transplantation
JF - Transplantation
IS - 2
ER -